SIEW JACKSON: Open Payments
NPI 1174212336 · WALDWICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$958 in 46 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $282 · 2025 $958
Food & beverage: $958
| Company | Payments | Amount |
|---|---|---|
| Stemline Therapeutics Inc. | 2 | $142 |
| AstraZeneca Pharmaceuticals LP | 7 | $109 |
| Novo Nordisk Inc | 5 | $89 |
| GlaxoSmithKline, LLC. | 5 | $86 |
| GENZYME CORPORATION | 1 | $80 |
| Amgen Inc. | 4 | $68 |
| Almatica Pharma LLC | 3 | $51 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $43 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| PFIZER INC. | 2 | $35 |
Products named: Orserdu, FARXIGA, QFITLIA, OTEZLA, TRELEGY ELLIPTA, LOREEV XR, Kerendia, XIFAXAN.
Industry payments across NJ — which companies pay providers there.
